Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Paliperidone 150mg/1.5ml prolonged-release inj pf syringes
0402020ABAAADAD
|
Paliperidone (Injection) | Paliperidone | Central Nervous System | 1,511 |
|
Paliperidone 100mg/1ml prolonged-release inj pf syringes
0402020ABAAACAC
|
Paliperidone (Injection) | Paliperidone | Central Nervous System | 1,299 |
|
Paliperidone 75mg/0.75ml prolonged-release inj pf syringes
0402020ABAAABAB
|
Paliperidone (Injection) | Paliperidone | Central Nervous System | 754 |
|
Paliperidone 50mg/0.5ml prolonged-release inj pf syringes
0402020ABAAAAAA
|
Paliperidone (Injection) | Paliperidone | Central Nervous System | 433 |
|
Paliperidone 525mg/2.625ml prolonged-release inj pf syringes
0402020ABAAAIAI
|
Paliperidone (Injection) | Paliperidone | Central Nervous System | 77 |
|
Paliperidone 350mg/1.75ml prolonged-release inj pf syringes
0402020ABAAAHAH
|
Paliperidone (Injection) | Paliperidone | Central Nervous System | 65 |
|
Paliperidone 263mg/1.315ml prolonged-release inj pf syringes
0402020ABAAAGAG
|
Paliperidone (Injection) | Paliperidone | Central Nervous System | 47 |
|
Paliperidone 175mg/0.875ml prolonged-release inj pf syringes
0402020ABAAAFAF
|
Paliperidone (Injection) | Paliperidone | Central Nervous System | 31 |
|
Paliperidone 700mg/3.5ml prolonged-release inj pf syringes
0402020ABAAAKAK
|
Paliperidone (Injection) | Paliperidone | Central Nervous System | 2 |
|
Paliperidone 1g/5ml prolonged-release inj pf syringes
0402020ABAAAJAJ
|
Paliperidone (Injection) | Paliperidone | Central Nervous System | 1 |
|
Paliperidone 150mg/1.5ml inj and Paliperidone 100mg/1ml inj
0402020ABAAAEAE
|
Paliperidone (Injection) | Paliperidone | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.